Laser cataract surgery reduces phaco emulsification times

Laser cataract surgery reduces phaco emulsification times

Yet more articles have appeared discussing the reduction in phacoemulsification times when performing femtosecond laser cataract surgery.
Firstly this one which has just appeared in Ocular Surgery News.

Femtosecond laser significantly reduces ultrasound in phaco
21 November 2013
NEW ORLEANS — Femtosecond laser pretreatment significantly reduced the need for ultrasound in lens fragmentation before phacoemulsification, a speaker told colleagues here.

“We are very close to our final goal to treat all patients without ultrasound ,” Tim Schultz, MD, said at the American Academy of Ophthalmology meeting. “Our analysis shows many new possibilities for new techniques.”

Schultz presented for H. Burkhard Dick, MD, who was unable to attend.

The prospective clinical trial included 2,400 cases treated with femtosecond laser pretreatment or manual lens fragmentation; 1,000 eyes underwent manual lens fragmentation, and 1,400 eyes underwent laser pretreatment with the Catalys femtosecond laser (OptiMedica). The Stellaris (Bausch + Lomb) was used to perform phacoemulsification.

Inclusion criteria were cataracts graded 1 to 4 on the Lens Opacities Classification System III (LOCS III), pupil size larger than 6 mm and age older than 22 years.

Results showed that 90% of LOCS III grade 2 cases, 66% of grade 3 cases and 63% of grade 4 cases were treated without ultrasound. Overall, 70% of patients were treated without ultrasound, Schultz said.

After ultrasound settings, phaco tip, grid size and other settings were changed and repetition rates were increased, 100% of grade 2 cases, 98% of grade 3 cases and 87% of grade 4 cases were treated without ultrasound. Overall, 95% of patients were treated without ultrasound.

Effective phacoemulsification time was reduced by 99%, Schultz said.

And also this one

Smaller fragmentation pattern found to reduce phaco time, power
18 November 2013
NEW ORLEANS — In a study comparing effective phacoemulsification time and power of different fragmentation patterns in femtosecond laser-assisted cataract surgery, researchers found that a smaller pattern reduced these variables, according to a poster.

The Catalys (Abbott Medical Optics) was used in 125 eyes of 102 patients with either the Quadrant or Complete pattern, according to the poster presented here at the American Academy of Ophthalmology meeting.

The effective phacoemulsification time (EPT) for the Quadrant and Complete groups was 29.47 seconds and 16.31 seconds, respectively, and the mean phaco power was 8.07% and 4.77%, respectively, according to the abstract.

The effect of reduced EPT and power was even greater in eyes with advanced cataract, according to Minoru Tomita, MD, PhD, and Mariko Mita, MD, PhD.

The authors also noted in the poster that the Catalys achieved “excellent results in terms of visual acuity at 3 months, indicating that the Catalys is safe and effective.”

This is in addition to the article by Brendan Vote from Tasmania below  which showed a reduced phaco emulsification time with femto cataract

 

Clin Experiment Ophthalmol. 2013 Jul;41(5):455-62. doi: 10.1111/ceo.12025. Epub 2012 Dec 10.

Femtosecond laser-assisted cataract surgery compared with conventional cataract surgery.

Source

Tasmanian Eye Institute, 36 Thistle Street West, Launceston, TAS 7250, Australia.

Abstract

BACKGROUND:

To investigate the safety and efficacy of the Catalys (Optimedica, Santa Clara, CA, USA) femtosecond laser-assisted cataract surgery system compared with conventional phacoemulsification cataract extraction.

DESIGN:

Prospective, consecutive, parallel cohort study.

PARTICIPANTS:

The first 200 eyes undergoing conventional cataract surgery to the first 200 eyes undergoing femtosecond laser-assisted cataract surgery between April and July 2012.

METHODS:

Femtosecond laser-assisted cataract surgery involved anterior capsulotomy and lens fragmentation based on optical coherence tomography-guided treatment mapping. Conventional cataract surgery involved manual continuous curvilinear capsulorhexis. Both procedures were completed by standard phacoemulsification and insertion of an intraocular lens.

MAIN OUTCOME MEASURES:

Effective phacoemulsification time and intraoperative complication rates.

RESULTS:

Patient demographics were similar between both groups. There was no statistically significant difference in intraoperative complications between femtosecond laser-assisted cataract surgery and conventional surgery. There was one posterior capsule rupture in both groups (0.5%; not significant). One hundred per cent of cases treated with the femtosecond laser had a complete capsulotomy. Vacuum time decreased with experience. Effective phacoemulsification time was reduced by 70% in the femtosecond group (P < 0.0001). Twenty-six cases in the femtosecond group versus one case in the conventional group had 0 effective phacoemulsification time (P < 0.0001).

CONCLUSION:

Femtosecond laser-assisted cataract surgery appears to be as safe as conventional cataract surgery in the short term and results in significantly lower effective phacoemulsification time. Although it may allow for greater efficiency and decreased postoperative complications, further research is needed into long-term safety aspects such as corneal endothelial cell loss.

 

 

What all this is leading to, is further evidence that surgery performed with femto second lasers is safer and less likely to lead to corneal decompensation due to endothelial cell loss. This is especially important in patients with compromised corneas such as Fuch’s etc.

Cataract surgery in difficult patients

Cataract surgery in difficult patients

I am often asked wether it is possible to perform cataract surgery on patients with deformities such as kyphosis or other back condition that prevents them from lying flat. The answer is generally a qualified ‘yes’.
There is no doubt that surgery in these patients is difficult for both surgeon and patient. Complications are more likely to occur if there is poor visualization, if the patient is constantly moving or is confused or if there is poor access such as a prominent brow, deep set eye or small eye.

The patient with back problems is not generally much of a problem as we have quite sophisticated theatre tables that can be set in virtually any position. The patient pictured above is a good example of this. This was a woman who had quite severe kyphosis and was permanently hunched. The theatre table that we used was able to cope to and extent but we also required to pack numerous foam blocks under her head. The table was tilted to allow the face to be horizontal with her body ‘up in the air’.

The more challenging patient, is the moving one. Occasional, patients with early dementia, become disoriented particularly when any sedation is used. They may not be aware that there are having surgery and can become distressed and almost impossible to operate on. Further attempts at sedation often results in more confusion and agitation. In these cases, a general anaesthetic may be required. The moving patient is no doubt one of the most difficult to deal with. For Surgeons accustomed to operating under topical anaesthesia, this is not as disconcerting as it would be for a surgeon who regularly performs surgery under a regional block. Most eye surgeons, particularly the older ones tend to still perform surgery under a block.

The patients with small pupils, dense white cataracts or opaque corneas are also difficult. The introduction of Trypan blue has made surgery in these patients much easier. Trypan blue was introduced by Prof Minas Coroneo in Sydney and is essentially a blue dye which stains the anterior capsule and allows better visualisation. Thus an opaque cornea becomes less of a challenge as the contrast between lens and capsule is better seen through the ‘fog’. Similarly, performing a capsulorhexis is made easier if there is contrast between the white lens and the blue capsule.

Small pupils, and floppy irises are another challenge. Patients who have been on long term eye medications, have pseudoexfoliation (PXF) syndrome or just plain don’t dilate can usually be managed with either iris hooks or a pupil stretch. More recently, Boris Malyugin, a Russian eye surgeon has introduced the ‘Malyugin’ ring which opens the small pupil with much less effort than before. Similarly, the patient on Alpha agonists such a Flomaxtra for bladder control end up with a floppy iris which is more likely to prolapse during surgery. Here again the use of a Malyugan ring has been transformative, converting a nightmare procedure into a straight forward one.

Malyugan Ring

Malyugan Ring

Many non eye surgeons often comment to me that eye surgery is easy. My response is to say that to a skilled pilot, flying is easy and to a skilled neurosurgeon, neurosurgery is easy. Cataract surgery in experienced hands is often easy but there are many situations in which it is far from easy and can be fraught with complications.

Laser cataract surgery night

Laser cataract surgery night

On Thursday the 31st, we had another successful laser cataract surgery education night. A number of local optometrists and optometry students attended for the CPD attracting evening which included a live demonstration of the laser in action.

Since the last one, the number of patients that have had this surgery has grown providing more data of its results.

Victoria Parade Surgical  Centre surgeons have now performed just over 200 cases of which about 140 were performed by myself. Eye surgeons still seem to be reluctant to transition to this new surgery. This is not surprising, as surgeons in general are very conservative by nature and reluctant to try something new that has a learning curve and might affect their results. An audit of my own results shows that now more than 75% of patients are achieving refractive results within 0.5 diopters of the desired aim.  I still have had no complications.

There is now no argument , after the Brendan vote paper, that shown that phaco times are down by 70%. This means that anyone who does not use this technology in cases of low endothelial counts such is Fuch’s, is open to litigation if corneal decompensation subsequently ensues.